IL-1Hy1
Alternative Names: IL1Hy1; Interleukin-1 receptor antagonist protein IL1Hy1Latest Information Update: 09 Aug 2002
At a glance
- Originator Nuvelo
- Class
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammatory bowel diseases; Rheumatoid arthritis
Most Recent Events
- 09 Aug 2002 Discontinued - Preclinical for Inflammatory bowel disease in USA (unspecified route)
- 09 Aug 2002 Discontinued - Preclinical for Rheumatoid arthritis in USA (unspecified route)
- 17 Feb 2000 Preclinical development for Inflammatory bowel disease in USA (Unknown route)